VectorB2B will be at “Phage Futures Congress 2021”

We are very pleased to announce that our Head of CMC, Teresa Duarte, will be a special guest of Cellexus joining the Phage Futures Congress.

Teresa will be participating in the panel session at Phage Futures, hosted by Adam Ostrowski, Technical Application Specialist at Cellexus. Other participants include Jonathan Kotula, Head of Science at Felix Biotechnology, Rodrigo García González, from the Bacteriophage Biology and Microbial Interactions Lab at the Pontificia Universidad Católica de Valparaíso, and Manuel Garrido, Production Specialist at TechnoPhage.

At this session upscaling of phage production for both medical and agrotechnical use will be discussed as well as the challenges, solutions, and experiences gained by academics, developed bioindustry and start-ups facing phage production.

The session is scheduled for Thursday 25 February at 10:45am EST / 15:45pm GMT.

This panel session is part of the Phage Futures Congress that takes place between Feb 24th and 26th. During the Congress experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond.

Read all the information at Phage Futures Congress 2021

More News

VectorB2B will exhibit at BIOSPAIN 2023 on 26-28 Sept in Barcelona

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of delegates came from outside of Spain. This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of […]

VectorB2B will exhibit at the European Drug Discovery Innovation Congress on 12-13 Sept in Barcelona

This event has a reputation for providing outstanding networking experiences with industry experts, thought leaders and fellow attendees to explore the latest trends, innovations, and challenges in the drug discovery landscape. Meet us at VectorB2B booth Link for the conference: https://worldbigroup.com/20th-Drug-Discovery/

VectorB2B is part of the Bio-Hub consortium aiming for the development of new biopharmaceuticals in Portugal targeting international markets

VectorB2B is one of the co-promoters of the Bio-Hub Agenda – a National R&D Platform for…

© 2024 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form